JESSICA MEYER: Open Payments
NPI 1629500970 · NEW HOLLAND, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,077 in 92 payments from 19 companies in 2025. Trend: 2023 $476 · 2024 $2,021 · 2025 $2,077
Food & beverage: $2,008Education: $69
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $479 |
| AstraZeneca Pharmaceuticals LP | 19 | $417 |
| ABBVIE INC. | 15 | $279 |
| Astellas Pharma US Inc | 6 | $207 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $96 |
| PFIZER INC. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Verona Pharma, Inc. | 2 | $62 |
| Dexcom, Inc. | 3 | $58 |
| Lundbeck LLC | 2 | $56 |
Products named: Wegovy, AIRSUPRA, Veozah, QULIPTA, BREZTRI, Kerendia, VRAYLAR, CAPLYTA.
Industry payments across PA — which companies pay providers there.
